Cargando…
The net cost of incorporating resistance testing into HIV/AIDS treatment in South Africa: a Markov model with primary data
BACKGROUND: Current guidelines for providing antiretroviral therapy (ART) in South Africa's public sector programme call for switching patients from first-line to second-line treatment upon virologic failure as indicated by two consecutive viral loads above 5000 copies/ml, but without laborator...
Autores principales: | Rosen, Sydney, Long, Lawrence, Sanne, Ian, Stevens, Wendy S, Fox, Matthew P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The International AIDS Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119176/ https://www.ncbi.nlm.nih.gov/pubmed/21575155 http://dx.doi.org/10.1186/1758-2652-14-24 |
Ejemplares similares
-
The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South Africa
por: Long, Lawrence C., et al.
Publicado: (2016) -
Economic Outcomes of Patients Receiving Antiretroviral Therapy for HIV/AIDS in South Africa Are Sustained through Three Years on Treatment
por: Rosen, Sydney, et al.
Publicado: (2010) -
The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012) -
Scaling up Xpert MTB/RIF technology: the costs of laboratory- vs. clinic-based roll-out in South Africa
por: Schnippel, Kathryn, et al.
Publicado: (2012) -
Treatment Outcomes and Cost-Effectiveness of Shifting Management of Stable ART Patients to Nurses in South Africa: An Observational Cohort
por: Long, Lawrence, et al.
Publicado: (2011)